Best African American Response to Asthma Drugs (BARD)

Trial Status: 


The purpose of this study is to find the best asthma treatment to add for African American/Black people who have asthma that is not well controlled on a low dose of inhaled steroid. This study will also try to find out if African American/Black adults and children differ in how they respond to the medications used in this study.


People 5 years of age and older, who are of African American/Black ancestry may be eligible to join this study. At this time, the University of Arizona is only enrolling participants age 5  years to 11 years. Enrollment for individuals 12 years and older has closed. 

For more information, visit the AsthmaNet web site.


The National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)


AsthmaNet Network


Principal Investigator: Fernando Martinez, MD

Contact Information:

Office: (520) 626-9543



AsthmaNet Network

Principal Investigator: 
Research Area: 
Clinical and Population Research